Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03534180
Title Venetoclax in Treating Participants With Recurrent or Refractory Mature T-Cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

peripheral T-cell lymphoma

Therapies

Venetoclax

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.